The scientist’s investigation covers issues in Internal medicine, Endocrinology, Insulin resistance, Adipose tissue and Lipidomics. His Internal medicine research incorporates elements of Microbiome and Diabetes mellitus. As a part of the same scientific family, Matej Orešič mostly works in the field of Endocrinology, focusing on Mitochondrion and, on occasion, Mitochondrial myopathy.
His work carried out in the field of Insulin resistance brings together such families of science as Saturated fatty acid, Inflammation and Polyunsaturated fatty acid. His Lipidomics study combines topics from a wide range of disciplines, such as Computational biology, Identification and Metabolic Stress. The study incorporates disciplines such as Body mass index, Type 2 diabetes and Gastrointestinal Microbiome in addition to Obesity.
His scientific interests lie mostly in Internal medicine, Endocrinology, Lipidomics, Metabolomics and Lipid metabolism. The various areas that Matej Orešič examines in his Internal medicine study include Diabetes mellitus and Type 1 diabetes. His study in Adipose tissue, Insulin, Lipogenesis, Carbohydrate metabolism and Lipolysis is done as part of Endocrinology.
He interconnects Schizophrenia and Cholesterol in the investigation of issues within Lipidomics. His studies in Metabolomics integrate themes in fields like Computational biology, Systems biology and Disease. His Lipid metabolism study improves the overall literature in Biochemistry.
Matej Orešič spends much of his time researching Internal medicine, Endocrinology, Disease, Lipid metabolism and Lipidomics. His Psychosis research extends to Internal medicine, which is thematically connected. Endocrinology and Oleoylethanolamide are frequently intertwined in his study.
Matej Orešič combines subjects such as Metabolome and Exposome, Environmental health with his study of Disease. His Lipid metabolism research is multidisciplinary, relying on both Type 1 diabetes and Immunology. His Lipidomics research integrates issues from Computational biology, Systems biology, Disease biomarker and Metabolomics.
Internal medicine, Endocrinology, Fibrosis, Fatty liver and Mass spectrometry are his primary areas of study. His Internal medicine study combines topics in areas such as Offspring, Pregnancy and Type 1 diabetes. His Endocrinology study is mostly concerned with Insulin resistance, Steatosis, Islet, Lithocholic acid and Lipid profile.
His work deals with themes such as Adiponutrin, NEFA, Fatty acid and Adipose tissue, Lipolysis, which intersect with Insulin resistance. His Fatty liver research is multidisciplinary, incorporating perspectives in Biomarker, Cochrane Library and Liver biopsy. His research in Mass spectrometry focuses on subjects like Detection limit, which are connected to Acetone.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data
Tomáš Pluskal;Sandra Castillo;Alejandro Villar-Briones;Matej Orešič.
BMC Bioinformatics (2010)
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
Sama I. Sayin;Annika Wahlström;Jenny Felin;Sirkku Jäntti.
Cell Metabolism (2013)
Human gut microbes impact host serum metabolome and insulin sensitivity
Helle Krogh Pedersen;Valborg Gudmundsdottir;Henrik B. Nielsen;Tuulia Hyötyläinen;Tuulia Hyötyläinen.
MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data
Mikko Katajamaa;Jarkko Miettinen;Matej Orešič.
The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
Aleksandar D. Kostic;Aleksandar D. Kostic;Dirk Gevers;Heli Siljander;Tommi Vatanen;Tommi Vatanen.
Cell Host & Microbe (2015)
Data processing for mass spectrometry-based metabolomics
Mikko Katajamaa;Matej Orešič.
Journal of Chromatography A (2007)
Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance
Miguel González López;Miguel González López;Luis Varela;María J. Sánchez Vazquez;Sergio Rodriguez-Cuenca.
Nature Medicine (2010)
The gut microbiota modulates host energy and lipid metabolism in mice.
Vidya R. Velagapudi;Rahil Hezaveh;Christopher S. Reigstad;Peddinti V. Gopalacharyulu.
Journal of Lipid Research (2010)
Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis
David Sebastián;María Isabel Hernández-Alvarez;Jessica Segalés;Eleonora Sorianello.
Proceedings of the National Academy of Sciences of the United States of America (2012)
Processing methods for differential analysis of LC/MS profile data.
Mikko Katajamaa;Matej Orešič.
BMC Bioinformatics (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: